Literature DB >> 12446270

Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.

James R Runo1, Cindy L Vnencak-Jones, Melissa Prince, James E Loyd, Lisa Wheeler, Ivan M Robbins, Kirk B Lane, John H Newman, Joyce Johnson, William C Nichols, John A Phillips.   

Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension in which the vascular changes originate in the small pulmonary veins and venules. The pathogenesis is unknown and any link with primary pulmonary hypertension (PPH) has been speculative. Mutations in the bone morphogenetic protein receptor II (BMPR2) gene have been identified in at least 50% of familial cases and in 25% of sporadic cases of PPH. We report a patient with documented PVOD whose mother had severe pulmonary hypertension. Sequencing of the patient's BMPR2 coding region revealed a del44C mutation in Exon 1 that is predicted to encode for a truncated protein. Analysis of DNA from family members suggests that this mutation was transmitted by the proband's mother to two of her four children. The finding of PVOD associated with a BMPR2 mutation reveals a possible pathogenetic connection with PPH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446270     DOI: 10.1164/rccm.200208-861OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

1.  Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates.

Authors:  C L Cua; A Blankenship; A L North; J Hayes; L D Nelin
Journal:  Pediatr Cardiol       Date:  2007-05-05       Impact factor: 1.655

2.  Pulmonary veno-occlusive disease in a pediatric hematopoietic stem cell transplant patient: a cautionary tale.

Authors:  M S Zinter; A Melton; A J Sabnis; C C Dvorak; B M Elicker; H M Nawaytou; R J Kameny; J R Fineman
Journal:  Leuk Lymphoma       Date:  2017-09-28

3.  Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Authors:  Christa F Gaskill; Erica J Carrier; Jonathan A Kropski; Nathaniel C Bloodworth; Swapna Menon; Robert F Foronjy; M Mark Taketo; Charles C Hong; Eric D Austin; James D West; Anna L Means; James E Loyd; W David Merryman; Anna R Hemnes; Stijn De Langhe; Timothy S Blackwell; Dwight J Klemm; Susan M Majka
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

4.  Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.

Authors:  Christa Gaskill; Shennea Marriott; Sidd Pratap; Swapna Menon; Lora K Hedges; Joshua P Fessel; Jonathan A Kropski; DeWayne Ames; Lisa Wheeler; James E Loyd; Anna R Hemnes; Dennis R Roop; Dwight J Klemm; Eric D Austin; Susan M Majka
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 5.  The role of genetics in pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

6.  Protein phosphatase 1γ isoforms linked interactions in the brain.

Authors:  Sara L C Esteves; Luís Korrodi-Gregório; Cândida Z Cotrim; Paula J M van Kleeff; Sara C Domingues; Odete A B da Cruz e Silva; Margarida Fardilha; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2012-10-19       Impact factor: 3.444

Review 7.  The genetics of pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 8.  The genetic basis of pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  Hum Genet       Date:  2014-01-21       Impact factor: 4.132

Review 9.  Leukotrienes in pulmonary arterial hypertension.

Authors:  Wen Tian; Xinguo Jiang; Yon K Sung; Jin Qian; Ke Yuan; Mark R Nicolls
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 10.  Metabolic Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Tufik R Assad; Anna R Hemnes
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.